Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Salvatore T, Butera"'
Autor:
P J Klasse, Celia C LaBranche, Thomas J Ketas, Gabriel Ozorowski, Albert Cupo, Pavel Pugach, Rajesh P Ringe, Michael Golabek, Marit J van Gils, Miklos Guttman, Kelly K Lee, Ian A Wilson, Salvatore T Butera, Andrew B Ward, David C Montefiori, Rogier W Sanders, John P Moore
Publikováno v:
PLoS Pathogens, Vol 12, Iss 9, p e1005864 (2016)
We have investigated the immunogenicity in rabbits of native-like, soluble, recombinant SOSIP.664 trimers based on the env genes of four isolates of human immunodeficiency virus type 1 (HIV-1); specifically BG505 (clade A), B41 (clade B), CZA97 (clad
Externí odkaz:
https://doaj.org/article/79dc137927414ccea029d363f51df72d
Autor:
Matthias G, Pauthner, Joseph P, Nkolola, Colin, Havenar-Daughton, Ben, Murrell, Samantha M, Reiss, Raiza, Bastidas, Jérémie, Prévost, Rebecca, Nedellec, Benjamin, von Bredow, Peter, Abbink, Christopher A, Cottrell, Daniel W, Kulp, Talar, Tokatlian, Bartek, Nogal, Matteo, Bianchi, Hui, Li, Jeong Hyun, Lee, Salvatore T, Butera, David T, Evans, Lars, Hangartner, Andrés, Finzi, Ian A, Wilson, Richard T, Wyatt, Darrell J, Irvine, William R, Schief, Andrew B, Ward, Rogier W, Sanders, Shane, Crotty, George M, Shaw, Dan H, Barouch, Dennis R, Burton
Publikováno v:
Immunity, 50(1), 241-252.e6. Cell Press
Immunity
Immunity
Summary Passive administration of HIV neutralizing antibodies (nAbs) can protect macaques from hard-to-neutralize (tier 2) chimeric simian-human immunodeficiency virus (SHIV) challenge. However, conditions for nAb-mediated protection after vaccinatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1e905e0b0b45fe979f6c4170b3072205
https://pure.amc.nl/en/publications/vaccineinduced-protection-from-homologous-tier-2-shiv-challenge-in-nonhuman-primates-depends-on-serumneutralizing-antibody-titers(14094cdb-6095-47d4-9e26-ac8d7196b3e7).html
https://pure.amc.nl/en/publications/vaccineinduced-protection-from-homologous-tier-2-shiv-challenge-in-nonhuman-primates-depends-on-serumneutralizing-antibody-titers(14094cdb-6095-47d4-9e26-ac8d7196b3e7).html
Autor:
Jérémie Prévost, Richard T. Wyatt, Ian A. Wilson, Benjamin von Bredow, Andrés Finzi, William R. Schief, Matthias Pauthner, Jeong Hyun Lee, David T. Evans, Darrell J. Irvine, Dan H. Barouch, Daniel W. Kulp, Ben Murrell, Peter Abbink, Joseph P. Nkolola, Salvatore T. Butera, Samantha M. Reiss, Andrew B. Ward, Bartek Nogal, Lars Hangartner, Dennis R. Burton, Hui Li, George M. Shaw, Rogier W. Sanders, Colin Havenar-Daughton, Rebecca Nedellec, Raiza Bastidas, Talar Tokatlian, Shane Crotty, Matteo Bianchi, Christopher A. Cottrell
SUMMARYPassive administration of HIV neutralizing antibodies (nAbs) can protect macaques from hard-to-neutralize (Tier 2) chimeric simian-human immunodeficiency virus (SHIV) challenge. However, conditions for nAb-mediated protection following vaccina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d3234bb7ffca9eda67d86a9a30e024f
Autor:
Gabriel Ozorowski, Rajesh P. Ringe, Marit J. van Gils, Rogier W. Sanders, John P. Moore, Ian A. Wilson, David C. Montefiori, Per Johan Klasse, Thomas J. Ketas, Albert Cupo, Kelly K. Lee, Miklos Guttman, Celia C. LaBranche, Salvatore T. Butera, Michael Golabek, Andrew B. Ward, Pavel Pugach
Publikováno v:
PLoS Pathogens, Vol 12, Iss 9, p e1005864 (2016)
PLoS Pathogens
PLoS pathogens, 12(9). Public Library of Science
PLoS Pathogens
PLoS pathogens, 12(9). Public Library of Science
We have investigated the immunogenicity in rabbits of native-like, soluble, recombinant SOSIP.664 trimers based on the env genes of four isolates of human immunodeficiency virus type 1 (HIV-1); specifically BG505 (clade A), B41 (clade B), CZA97 (clad
Autor:
Suvanna Asavapiriyanont, Nathan Shaffer, Jordan W. Tappero, Nirun Vanprapar, Janet M. McNicholl, W. Bhanich Supapol, Janet Raboud, Rupert Kaul, Margaret Millson, Salvatore T. Butera, Prasad S Kulkarni, Robert S. Remis, Philip A. Mock, Michelle S. McConnell
Publikováno v:
The Journal of Infectious Diseases. 200:227-235
BACKGROUND: GB virus C (GBV-C) is an apathogenic virus that inhibits human immunodeficiency virus (HIV) replication in vitro. Mother-to-child transmission (MTCT) of GBV-C has been observed in multiple small studies. Our study examined the rate and co
Autor:
Bette T. Korber, Smita Kulkarni, Robert C. Bollinger, Francine E. McCutchan, Alan Lapedes, Lynn Morris, Haili Tang, Salvatore T. Butera, Victoria R. Polonis, Ramesh S. Paranjape, Tanmoy Bhattacharya, Dennis Ellenberger, Marcus Daniels, Ming Zhang, Sandrasegaram Gnanakaran, Ming Li, David C. Montefiori
Publikováno v:
Virology. 385(2):505-520
Little is known about the neutralization properties of HIV-1 in India to optimally design and test vaccines. For this reason, a functional Env clone was obtained from each of ten newly acquired, heterosexually transmitted HIV-1 infections in Pune, Ma
Autor:
Prasad S Kulkarni, Nathan Shaffer, Philip A. Mock, Tawee Chotpitayasunondh, Rupert Kaul, Salvatore T. Butera, Michelle S. McConnell, Margaret Millson, Anuvat Roongpisuthipong, Janet Raboud, Robert S. Remis, Jordan W. Tappero, Janet M. McNicholl, Wendy Bhanich Supapol, Mary Culnane
Publikováno v:
The Journal of Infectious Diseases. 197:1369-1377
Prolonged coinfection with GB virus C (GBV-C) has been associated with improved survival in human immunodeficiency virus (HIV)-infected adults. We investigated whether maternal or infant GBV-C infection was associated with mother-to-child transmissio
Autor:
Denise J. Jamieson, Pooja Bansil, Salvatore T. Butera, Michael K. Lindsay, Ann Duerr, Chris C. Ibegbu, Yongxian Xu, Athena P. Kourtis, Regan N. Theiler
Publikováno v:
The Journal of Infectious Diseases. 195:965-972
Background. Transmission of human immunodeficiency virus (HIV) to the infant through breast-feeding is a major problem worldwide; however, the biological circumstances of such transmission remain unclear. Little characterization of breast milk CD4 +
Autor:
James Mitchell, Christopher F McConville, Gustavo F. Doncel, Clare McCoy, Priya Srinivasan, Angela Holder, Ron A. Otten, David R. Friend, James M. Smith, Salvatore T. Butera, R. Karl Malcolm
Publikováno v:
Drug delivery and translational research. 5(1)
This study describes the preclinical development of a matrix-type silicone elastomer vaginal ring device designed to provide controlled release of UC781, a non-nucleoside reverse transcriptase inhibitor. Testing of both human- and macaque-sized rings
Publikováno v:
BioProcessing Journal. 5:43-51